The expression of SLC12A5 in normal ovaries and in benign and malignant epithelial ovarian tumors*
| SLC12A5 protein | |||
| All cases | Low expression | High expression | |
| Normal ovaries | 30 | 30 (100%) | 0 (0) |
| Cystadenomas | 30 | 28 (93%) | 2 (7%) |
| Borderline tumors | 30 | 25 (83%) | 5 (17%) |
| Invasive carcinomas | 147 | 92 (63%) | 55 (37%) |
*Values are n (%). A significant increasing frequency of intensive expression of SLC12A5 was observed in cystadenomas, in borderline tumors, and in invasive carcinomas (P<0.01, chi-square test for trend).